Literature DB >> 25794032

Increased Incidence of Rhino-Orbital-Cerebral Mucormycosis After Colorado Flooding.

Brett W Davies1, Jesse M Smith, Eric M Hink, Vikram D Durairaj.   

Abstract

In September 2013, central Colorado experienced a record amount of rainfall resulting in widespread flooding. Within 1 month of the flooding, 4 patients presented to the authors' institution with rhino-orbital-cerebral mucormycosis. This represents the largest number of cases ever recorded over a 1-month period. The authors hypothesize that the combination of immunocompromised status and environmental exposure resulted in the increased incidence.

Entities:  

Mesh:

Year:  2017        PMID: 25794032     DOI: 10.1097/IOP.0000000000000448

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  5 in total

Review 1.  Reconstruction in Rhino-Orbito-Cerebral Mucormycosis Survivors: A Systematic Review.

Authors:  Ved Prakash Rao Cheruvu; Manal M Khan
Journal:  Eplasty       Date:  2022-06-14

Review 2.  Fungal infections of the orbit.

Authors:  Bipasha Mukherjee; Nirav Dilip Raichura; Md Shahid Alam
Journal:  Indian J Ophthalmol       Date:  2016-05       Impact factor: 1.848

Review 3.  A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare.

Authors:  Kathleen P Hartnett; Brendan R Jackson; Kiran M Perkins; Janet Glowicz; Janna L Kerins; Stephanie R Black; Shawn R Lockhart; Bryan E Christensen; Karlyn D Beer
Journal:  J Fungi (Basel)       Date:  2019-07-24

4.  Rise of the phoenix: Mucormycosis in COVID-19 times.

Authors:  Swati A Ravani; Garima A Agrawal; Parth A Leuva; Palak H Modi; Krisha D Amin
Journal:  Indian J Ophthalmol       Date:  2021-06       Impact factor: 1.848

Review 5.  Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread.

Authors:  Shreya Dogra; Akanksha Arora; Aashni Aggarwal; Gautam Passi; Akanksha Sharma; Gurpal Singh; Ravi P Barnwal
Journal:  Front Microbiol       Date:  2022-01-04       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.